1. Incidence Rates and Time Trends of Pancreatic Cancer in the Golestan Province, Northeastern Iran, 2006-2019

Sajjad Kaabe , Taghi Amiriani , Mehrdad Teimoorian* , Sima Besharat* , Faezeh Salamat, Susan Hasanpour-Heidari, SeyyedMehdi Sedaghat, Hamideh Sadeghzadeh, Gholamreza Roshandel

Arch Iran Med. 2024;27(9): 486-493. doi: 10.34172/aim.31168

PMCID: PMC11496600 PMID: 39465523 Scopus ID: 85206799543

Article

PDF

XML

Cited By:

Original Article

2. Aspirin Use and Risk of Pancreatic Ductal Adenocarcinoma: A Large Case-Control Study

Zahra Momayez Sanat , Sahar Masoudi , Seidamir Pasha Tabaeian, Maryam Jameh Shorani, Majid Soruri, Akram Pourshams*

Arch Iran Med. 2023;26(4): 181-185. doi: 10.34172/aim.2023.28

PMCID: PMC10685750 PMID: 38301077 Scopus ID: 85169686160

Article

PDF

XML

Cited By:

Original Article

3. Mutations in Known and Novel cancer Susceptibility Genes in Young Patients with Pancreatic Cancer

Sahar Alimirzaie, Ashraf Mohamadkhani, Sahar Masoudi, Erin Sellars, Paolo Boffetta, Reza Malekzadeh, Mohammad R. Akbari, Akram Pourshams*

Arch Iran Med. 2018;21(6): 228-233.

PMID: 29940740 Scopus ID: 85050404431

Article

PDF

Full Text

XML

Cited By:

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.